VTU Technology showcasing breakthrough technologies at BIO-International

news-releasesVALIDOGEN GmbH
May 26th 2015

Grambach, Austria: – Protein expression specialist VTU Technology will use the forthcoming BIO-International convention in Philadelphia to provide details of its latest technology developments and advances in its revolutionary Pichia pastoris protein production platform.

VTU is showcasing its groundbreaking Pichia technology that enables ultra-competitive production of proteins and development of economically viable protein production processes.

The platform has already yielded some of the highest protein yields ever recorded.

Tailored glycoproteins

Additionally VTU will feature its new glycoprotein production package – a combination of VTU’s proprietary Pichia pastoris protein production platform with RCT´s Pichia GlycoSwitch expression system to enable boosted production of tailored glycoproteins.

VTU will be a prominent presence in the Austrian Pavilion (Booth 2701) at BIO-International, which the company has attended regularly since 2008.

Dr. Thomas Purkarthofer, Head of Business Development, and Dr. Roland Weis, Head of Operations will lead VTU’s team at BIO-International. Both will be available for meetings and one-to-one conferences using the event’s sophisticated web-based networking system.

Powerful protein platform

“We see this event as one of the most important partnering conferences in the world for biotech companies,” commented Dr. Purkarthofer.

“Our message at this convention is very simple: that we can offer the world´s broadest and most powerful Pichia pastoris protein production platform enabling the cost-and time efficient production of biopharmaceuticals and any other recombinant proteins,” he added.

“The results that we’ve been able to achieve recently with our productivity enhancing protein production platform just confirm the power of the underlying technology,” said Dr. Purkarthofer.

About VTU Technology

VTU Technology, a leading contract research and development company, offers the broadest toolbox and most versatile technology platform available for Pichia pastoris recombinant protein expression / production enabling highest productivities delivering up to 25 g/L of secreted protein within a few weeks development time.

VTU´s yield-enhancing Pichia pastoris expression platform is based on its proprietary AOX1 promoter libraries and set of expression enhancing helper factors, several platform strains with different genetic backgrounds, elaborated cloning and transformation protocols, a high-throughput screening and cultivation regime combined with excellent know-how in fermentation and downstream process development for maximization of product yield and overall process performance.

Headquartered in Grambach/Graz, Austria, VTU Technology is a private company and a subsidiary of VTU Holding, an Austrian enterprise that combines several technology and engineering companies in chemistry, pharma and life science as well as in the energy industries.

More information at: /www.vtu-technology.com and www.vtu.com

About BIO-International 2015

The BIO-International® Convention is a flagship conference providing life science companies with further high caliber knowledge sharing and partnering opportunities. The convention attracts some 2,500 CEOs from the pharmaceutical and biotech industries.

The 2015 BIO-International Convention is a four-day event opening June 15 at the Pennsylvania Convention Center in central Philadelphia.

The BIO-International convention has been running since 2003 and consistently attracts executives from established and emerging pharma and biotech companies, along with academic researchers and private investors including venture capital and private equity and organizations developing companion diagnostics.

More than 15,500 people, from 66 countries, attended the 2014 convention in San Diego, California. The sophisticated One-on-One™ web-based partnering system was used to facilitate more than 29,000 meetings, involving more than 3,000 companies.

The Convention is organized by the US Biotechnology Industry Organization.

More information at: http://convention.bio.org